Product Name | Deprenyl |
Description |
Apoptosis Inhibitor |
Purity | >98% (TLC); NMR (Conforms) |
CAS No. | 14611-52-0 |
Molecular Formula | C13H17N·HCl |
Molecular Weight | 223.74 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | May be dissolved in water (25mg/mL) |
Source | Synthetic |
Appearance | White Solid |
SMILES | C[C@H](CC1=CC=CC=C1)N(C)CC#C |
InChI | InChI=1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1 |
InChIKey | IYETZZCWLLUHIJ-UTONKHPSSA-N |
Safety Phrases |
Classification: Harmful. May be harmful if inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R62- Possible risk of impaired fertility |
Cite This Product | Deprenyl (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-209) |
Alternative Names | N-Methyl-N-[(2R)-1-phenyl-2-propanyl]-2-propyn-1-amine, Selegiline |
Research Areas | Apoptosis, Cancer |
PubChem ID | 26757 |
Scientific Background | Deprenyl or Selegiline is a drug used for the treatment of early stage Parkinson’s (1), depression and senile dementia (2). It is a selective irreversable inhibitor of monoamine oxidase B (MAO-b). |
References |
1. Lachenmayer L., and Laux G. (2004) Curr Med Chem. 11(15): 2033-2043. 2. FDA US Food and Drug Administration. Press Announcements Feb 28, 2006. www.fda.gov/newsevents/newsroom/pressannouncements/2006/ucm108607.htm |
Reviews
There are no reviews yet.